Paul Christopher Williams Cytek Biosciences, Inc. (CTKB) insider trading activity

Paul Christopher Williams is CHIEF OPERATING OFFICER of Cytek Biosciences, Inc.. Currently has a direct ownership of 16,473 shares of CTKB, which is worth approximately $88,789. The most recent transaction as insider was on Aug 19, 2024, when has been sold 4,195 shares (Common Stock) at a price of $5.53 per share, resulting in proceeds of $23,198. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.5K

66.36% 3M change

1661.82% 12M change

Total Value Held $88,789

Paul Christopher Williams Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 19 2024	SELL Payment of exercise price or tax liability	$23,198 $5.53 p/Share	4,195 Reduced 20.3%	16,473 Common Stock
Aug 19 2024	BUY Exercise of conversion of derivative security	-	10,766 Added 35.09%	19,917 Common Stock
May 20 2024	SELL Payment of exercise price or tax liability	$17,444 $5.96 p/Share	2,927 Reduced 22.82%	9,902 Common Stock
May 20 2024	BUY Exercise of conversion of derivative security	-	7,512 Added 38.11%	12,198 Common Stock
Mar 11 2024	SELL Payment of exercise price or tax liability	$3,451 $7.22 p/Share	478 Reduced 8.25%	5,317 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	-	1,227 Added 17.47%	5,795 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$3,284 $8.38 p/Share	392 Reduced 7.9%	4,568 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	1,006 Added 16.86%	4,960 Common Stock
Nov 18 2023	SELL Payment of exercise price or tax liability	$11,529 $5.98 p/Share	1,928 Reduced 32.78%	3,954 Common Stock
Nov 18 2023	BUY Exercise of conversion of derivative security	-	4,947 Added 53.42%	4,313 Common Stock
Aug 18 2023	SELL Payment of exercise price or tax liability	$3,037 $8.46 p/Share	359 Reduced 27.74%	935 Common Stock
Aug 18 2023	BUY Exercise of conversion of derivative security	-	920 Added 41.55%	1,294 Common Stock
May 18 2023	SELL Payment of exercise price or tax liability	$1,598 $6.69 p/Share	239 Reduced 38.99%	374 Common Stock
May 18 2023	BUY Exercise of conversion of derivative security	-	613 Added 50.0%	613 Common Stock

PCW

Paul Christopher Williams

CHIEF OPERATING OFFICER

Fremont, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Value

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB

Account